Companies › BEAT

HEARTBEAM INC (BEAT)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001779372 · EDGAR filings · Updated 2026-07-24

HEARTBEAM INC (BEAT) has reported institutional ownership of 12.5%, with 37 institutional managers holding positions valued at $6.28M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (3)

• 2026-07-24 — Insider transaction reported (Form 4)
• 2026-07-24 — Insider transaction reported (Form 4)
• 2026-07-24 — Insider transaction reported (Form 4)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-02 — Current report (8-K) filed
• 2026-06-25 — DEFA14A filed
• 2026-06-24 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, HEARTBEAM INC has 37 institutional holders and institutional ownership of 12.5%.

Insider activity

Insiders reported 6 transactions (0 buys, 3 sells) across 9 reporting insiders, with a net reported value of −$1.08M.

Data flags from SEC filings

Related companies

Atossa Therapeutics Inc (ATOS) · MEDICUS PHARMA LTD (MDCX) · NERVGEN PHARMA CORP (NGEN) · INMUNE BIO INC (INMB) · APOLLOMICS INC (APLM) · CYPHERPUNK TECHNOLOGIES INC (CYPH)